Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | Madrid | Financials | Banking Services | 29.7% | €3.91B | -102.3x | €1.54 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.6% Downside | Upgrade to Pro+ | ||
Upgrade to Pro+ | Madrid | Consumer Cyclicals | Media & Publishing | 24.6% | €142.31M | 13.3x | €1.57 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Upgrade to Pro+ | Madrid | Real Estate | Real Estate Operations | 15% | €1.44B | 79.3x | 0.63 | €9.50 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Madrid | Utilities | Electrical Utilities & IPPs | 13.6% | €284.56M | 24.4x | 0.88 | €5 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Madrid | Real Estate | Residential & Commercial REITs | 5.5% | €169.10M | 10.7x | 0.19 | €11.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Madrid | Healthcare | Biotechnology & Medical Research | 0% | €59.78M | -9.9x | 0.12 | €1.74 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |